MIZUHO MEDY CO.,LTD. Logo

MIZUHO MEDY CO.,LTD.

4595 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
鳥栖市藤木町5番地の4
Sector:
Health Care
Industry:
Pharmaceuticals

Description

MIZUHO MEDY Co., Ltd., based in Tosu, Saga, Japan, specializes in in vitro diagnostics, offering a comprehensive range of innovative products. The company is renowned for its advanced nucleic acid amplification tests and rapid immunoassays catering to clinical, research, and agricultural applications. Notable offerings include the Smart Gene® series and the Quick Chaser line, which addresses various pathogens, including SARS-CoV-2 and RSV. Committed to quality, MIZUHO MEDY has achieved ISO 13485 certification for its operations, ensuring adherence to stringent quality management standards. With a focus on technological advancement, the company actively participates in international exhibitions, showcasing its commitment to healthcare innovation and improving diagnostic solutions.

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-04-02 06:17
Inside Information Statement
臨時報告書
Japanese 25.9 KB
2025-03-31 03:44
Internal Control over Financial Reporting
内部統制報告書-第48期(2024/01/01-2024/12/31)
Japanese 22.5 KB
2025-03-31 03:41
Regulatory News Service
確認書
Japanese 8.7 KB
2025-03-31 03:37
Annual Report
有価証券報告書-第48期(2024/01/01-2024/12/31)
Japanese 931.6 KB
2024-08-09 06:11
Regulatory News Service
確認書
Japanese 8.7 KB
2024-08-09 06:09
Interim Report
半期報告書-第48期(2024/01/01-2024/12/31)
Japanese 209.8 KB
2024-05-10 06:07
Regulatory News Service
確認書
Japanese 8.7 KB
2024-05-10 06:06
Quarterly Report
四半期報告書-第48期第1四半期(2024/01/01-2024/03/31)
Japanese 169.5 KB
2024-04-01 09:48
Inside Information Statement
臨時報告書
Japanese 21.6 KB
2024-03-29 02:02
Internal Control over Financial Reporting
内部統制報告書-第47期(2023/01/01-2023/12/31)
Japanese 22.5 KB
2024-03-29 01:59
Regulatory News Service
確認書
Japanese 8.7 KB
2024-03-29 01:56
Annual Report
有価証券報告書-第47期(2023/01/01-2023/12/31)
Japanese 967.0 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
D.Western Therapeutics Institute, Inc. Logo D.Western Therapeutics Institute, Inc. Japan 4576
EARNZ PLC Logo EARNZ PLC United Kingdom EARN
Eevia Health Plc Logo Eevia Health Plc Finland EEVIA
Egetis Therapeutics Logo Egetis Therapeutics Sweden EGTX
EIKEN CHEMICAL CO.,LTD. Logo EIKEN CHEMICAL CO.,LTD. Japan 4549
Eisai Co., Ltd. Logo Eisai Co., Ltd. Japan 4523
ELARIS AG Logo ELARIS AG Germany ELS
Enervit Logo Enervit Italy ENV
Enorama Pharma AB Logo Enorama Pharma AB Sweden ERMA
Enzymatica AB Logo Enzymatica AB Sweden ENZY